Allergan Plc (AGN) Files Form 4 Insider Buying : Maria Teresa Hilado Buys 661 Shares

Allergan Plc (AGN): Maria Teresa Hilado , CFO of Allergan Plc purchased 661 shares on Jun 2, 2016. The Insider buying transaction was reported by the company on Jun 6, 2016 to the Securities and Exchange Commission. The shares were purchased at $241.57 per share for a total value of $159,677.77 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on May 12, 2016, Nesli Basgoz (director) sold 459 shares at $225.10 per share price.On Aug 24, 2015, Brent L Saunders (CEO) purchased 1,000 shares at $301.94 per share price.Also, On Aug 24, 2015, Paul Bisaro (Exec Chairman) purchased 1,000 shares at $297.42 per share price.

Shares of Allergan plc Ordinary Shares (AGN) ended Friday, Jun 3, 2016 session in red amid volatile trading. The shares closed down -0.16 points or -0.06% at $246.96 with 39,67,262 shares getting traded. Post opening the session at $245.92, the shares hit an intraday low of $242.2 and an intraday high of $248.75 and the price vacillated in this range throughout the day. The company has a market cap of $97,687 M and the number of outstanding shares has been calculated to be 39,55,56,910 shares. The 52-week high of Allergan plc Ordinary Shares is $340.34 and the 52-week low is $195.5.

Allergan plc Ordinary Shares Money Flow Index Chart

Company has been under the radar of several Street Analysts.Allergan plc Ordinary Shares is Reiterated by Mizuho to Neutral while Lowering the Price Target of the company shares to $ 232 from a previous price target of $250 . The Rating was issued on May 13, 2016.Allergan plc Ordinary Shares is Downgraded by Piper Jaffray to Neutral while Lowering the Price Target of the company shares to $ 238 from a previous price target of $311 . Earlier the firm had a rating of Overweight on the company shares. The Rating was issued on Apr 18, 2016.Allergan plc Ordinary Shares is Initiated by Guggenheim to Neutral. The Rating was issued on Apr 18, 2016.Allergan plc Ordinary Shares is Resumed by Goldman to Buy and the brokerage firm has set the Price Target at $275. The Rating was issued on Apr 18, 2016.Allergan plc Ordinary Shares is Resumed by Morgan Stanley to Overweight and the brokerage firm has set the Price Target at $300. The Rating was issued on Apr 7, 2016.

Leave a Reply

Allergan plc Ordinary Shares - Is it time to Sell?

Top Brokerage Firms are advising their investors on Allergan plc Ordinary Shares. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.